Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-024996
Filing Date
2025-08-20
Accepted
2025-08-20 18:13:38
Documents
1
Period of Report
2025-04-28

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5309
  Complete submission text file 0001641172-25-024996.txt   6875
Mailing Address 104-110 AVENUE C BAYONNE NJ 07002
Business Address
Stetz Gary S. (Reporting) CIK: 0001532793 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41210 | Film No.: 251237987

Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Issuer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)